Copy number variants visible with the light microscope have been described as euchromatic variants (EVs) and EVs with extra G-light material at 8q21.2 have been reported only once before. We report four further patients with EVs of 8q21.2 ascertained for clinical (3) or reproductive reasons (1). Enhanced signal strength from two overlapping bacterial artificial chromosomes (BACs) and microarray analysis mapped the EV to a 284-kb interval in the reference genome. This interval consists of a sequence gap flanked by segmental duplications that contain the 12-kb components of one of the largest Variable Number Tandem Repeat arrays in the human genome. Using digital NanoString technology with a custom probe for the RNA exonuclease 1 homologue (S. cerevisiae)-like 1 (REXO1L1) gene within each 12-kb repeat, significantly enhanced diploid copy numbers of 270 and 265 were found in an EV family and a median diploid copy number of 166 copies in 216 controls. These 8q21.2 EVs are not thought to have clinical consequences as the phenotypes of the probands were inconsistent, those referred for reproductive reasons were otherwise phenotypically normal and the REXO1L1 gene has no known disease association. This EV was found in 4/3078 (1 in 770) consecutive referrals for chromosome analysis and needs to be distinguished from pathogenic imbalances of medial 8q. The REXO1L1 gene product is a marker of hepatitis C virus (HCV) infection and a possible association between REXO1L1 copy number and susceptibility to HCV infection, progression or response to treatment has not yet been excluded.
INTRODUCTION
At least 1% of individuals have a copy number variation (CNV) larger than 1 Mb 1 and, when copy number is high enough, CNVs become visible with the light microscope. These have been described as euchromatic variants (EVs) 2 (Chromosome Anomaly Collection) and involve (1) constitutional cytogenetic amplification of known CNV regions or (2) duplication, triplication or deletion of large segmentally duplicated (SD) euchromatic tracts which may include heterochromatin and accompany pseudo-dicentric variants (Table 1) . Most of the EVs are clinically innocuous but the 8p23.1 EV has been associated with a number of traits [5] [6] [7] [8] and the 4p16.1 EV co-segregated with microtia. 4 EVs need to be distinguished from pathological imbalances with which they may be similar or even identical under the light microscope. 5, 19, 21, 24, 25 Recently, Manvelyan et al 9 reported three patients of Middle European and Japanese descent with a microscopically visible CNV of 8q21.2. This CNV was characterised by a 60% increase in the signal strength from a single bacterial artificial chromosome (BAC) but an extra copy of a single BAC of B123 kb would not normally account for the microscopic visibility of this 8q21.2 EV. Here, we have confirmed the existence of this 8q21.2 EV in four new patients from Canada (Table 2 ) and set out to refine the location and extent of this EV. We have used digital NanoString technology to quantify the copy number of the variable number tandem repeat (VNTR) array within the EV and find that expansion of this 8q21.2 VNTR is common and most likely to account for the microscopic visibility of the 8q21.2 EV. We estimate the prevalence of the 8q21.2 EV among postnatal referrals for chromosome analysis and suggest that CNV of the RNA exonuclease 1 homologue (S. cerevisiae)-like 1 (REXO1L1) gene cluster within the VNTR may be related to susceptibility to hepatitis C infection.
METHODS
Chromosomes were prepared and analysed using standard procedures on a total of 3078 consecutive clinical referrals for peripheral blood analysis over a 21 month period. Single-or dual-colour fluorescence in situ hybridisation (FISH) was performed with BACs from 8q21.2, a centromere probe for chromosome 8 (D8Z2) and, for Patient 4, a centromere probe for chromosomes 9 (D9Z3) with a centromere probe for chromosome 11 as a control (Cytocell, Cambridge, UK). DNA was extracted from peripheral blood using Puregene DNA Isolation Kits (Gentra, Minneapolis, MN, USA) and used for microarray analysis with Affymetrix Cytogenetics 2.7M (Patient 1) or Affymetrix Cytoscan HD (Patient 4) microarrays according to the manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The Affymetrix CEL data files were converted into CYCHP files using the annotation files na30.2 (Patient 1; 2.7M array) or na32.1 (Patient 4; Cytoscan HD array) and the microarray data were analysed using the Affymetrix Chromosome Analysis Suite (ChAS) Software v1.1 (Patient 1; 2.7M array) or v1.2 (Patient 4; Cytoscan HD array) (Affymetrix). The reference model file was provided by Affymetrix. Quality control parameters were SNPQC Z1.1 and MAPD r0.27 (Patient 1; 2.7M array) or SNPQC Z15 and MAPD r0.25 (Patient 4; Cytoscan HD array). Base pair coordinates correspond or have been converted to release GRCh37 (hg19). DNA for NanoString analysis was extracted using standard methods and used for genomic copy number analysis with a custom NanoString code set comprising 10 normalisation probes targeting invariant autosomal loci, and 27 custom probes targeting highly CNV sites including one targeting the REXO1L1 gene cluster (probe sequence GTTTCCCCTAC AAGCGCTCCCTCAGGAATCTCGCGGCCGACTACCTGGCACAGATCATCC AGGACAGCCA). Patient DNA samples and 216 anonymous controls of selfreported European ancestry were processed using the NanoString nCounter Analysis System (NanoString Technologies, Seattle, WA, USA) 26 according to the manufacturer's instructions. The ethnicity of patients and/or parents was based on their self-reported national origins. 
Clinical details

RESULTS
Our results and those of Manvelyan et al 9 are summarised in Table 2 .
Karyotyping Additional G-light material was found at band 8q21.2 in all four index patients (Figures 1a-d ) among 3078 consecutive clinical referrals for peripheral blood analysis over a 21-month period. The additional material could have been the result of duplication, insertion, paracentric inversion or conformational alteration. However, the banding pattern was not consistent with an inversion and the extra material appeared to be cytogenetically identical to the microscopically visible CNVs described by Manvelyan et al. 9 The same variant was found in the father of Patient 4 ( Figure 1e ) and, following microarray analysis of Patient 4 (see below), mosaic trisomy 9 was 
Molecular genetics
Pulse-field electrophoresis (PFGE) had previously demonstrated that the 8q21.2 SDs contain elements of a tandem VNTR array consisting of 50-150 copies of a 12-kb repeat that spanned 0.6-1.7 Mb in two pedigrees. 27 We used digital NanoString technology with a custom probe for the REXO1L1 gene cluster to determine total (diploid) copy number of the 12 kb repeat. There was a close linear correlation between total copy number measured using PFGE Southern blot and the NanoString nCounter Analysis System (R 2 ¼ 0.98) (Figure 3a) . Total copy numbers of 265 and 270 were found in Patient 4 and her Figure 3b ) and, by comparison, the copy numbers in the EV family were greater than the 99th centile and significantly higher using the Mann-Whitney Rank Sum Test (P ¼ 0.018).
DISCUSSION
Our results map the 8q21.2 EVs to the sequence gap and flanking SDs in distal 8q21.2 that are clearly larger than 284 kb in the reference genome (Figures 2e and g ) and most likely to underlie this EV. Compared with the other 16 EVs in Table 1 , the 8q21.2 EVs have by far the smallest amplicon, the highest copy number and, in common with the 4p16.1 and 8p23.1 EVs, are flanked by SDs of the kind that underlie the majority of other EVs. The NanoString analysis indicates that an average of 173 diploid copies of the REXO1L1 gene cluster and 12 kb repeat are present within the 8q21.2 VNTR in our 216 controls. This implies that an average chromosome 8 contains 87 copies spanning over 1 Mb or almost half of band 8q21.2 which is a predicted 2.3 Mb in the UCSC browser 28 or an estimated 2.1 Mb (assuming that 8q21.2 is 2% of 8q 29 and that 8q is 105 Mb 30 ). If accompanied by an average chromosome 8, then the 265 and 270 copies in Patient 4 and her father imply EV chromosomes withB180 copies spanning over 2.1 Mb. Thus, given the B2:1 ratio of the enhanced FISH signals (Figures 2a-d) , 9 the simplest interpretation of our results is that an average VNTR array ofB90 copies is duplicated to give an EV chromosome ofB180 copies, a diploid total of 270 copies and a differential length of at least 1 Mb (Figure 2g) . However, the EV FISH signals could not be resolved into separate blocks (Figures 2a and c) and there is a relatively even distribution of copy numbers from a minimum of 97 to a maximum of 277 in the 216 controls (Figure 3b ). In addition, the copy numbers in EV carriers are significantly higher than the great majority of controls and above the 99th centile of the control range. We therefore propose that expansion of the VNTR array is most likely to underlie the 8q21.2 EVs, and that their microscopic visibility reflects the combination of an expanded VNTR array on the EV chromosome with an average or smaller than average VNTR array on the homologous chromosome 8. An analogous situation was found for the beta defensin repeat underlying the 8p23.1 EV: this was detected in rare instances of high diploid copy numbers unequally split between homologous chromosomes 8; 31 only subsequently did the frequency of similar diploid copy numbers in control populations imply the presence of individuals with above average copy numbers on both homologous chromosomes. 5 Interphase FISH has been used to determine relative haploid copy numbers but becomes impractical when amplicon size is small and copy number very high. 32 Further investigations will be needed of EV and non-EV carriers in larger families using quantitative allele-specific copy number techniques 33 to confirm or exclude our proposal.
In the meantime, the microscopically visible CNV of 8q21.2 is not believed to be population specific now that it has been described in (Table 2) . These seven were ascertained with congenital anomalies, autism, secondary amenorrhoea, infertility, miscarriages and a family history of intellectual difficulties and cystic fibrosis (Table 2 ). However, this EV is unlikely to be a cause of congenital anomalies or autism because: (1) there was no consistency in the indications in Patients 2, 3 and 4, and the congenital anomalies in Patient 4 were most likely explained by her trisomy 9 mosaicism; (2) the three patients referred for reproductive reasons were otherwise normal (Patient 1; Manvelyan et al, 9 Patients 1 and 2); (3) the 12-kb VNTR repeat array contains only the REXO1L1 gene cluster that has no known pathology to date; (4) the variant region overlaps RP11-96G1 which is a common benign CNV 34 and corresponds with locus 4603a in the Database of Genome Variants (DGVs). 35 A possible association with infertility and/or miscarriage 9 would need testing in much larger cohorts and is more likely to reflect bias of ascertainment. 36 This EV was found in 4/3078 (1 in 770) consecutive referrals over a 21-month period which suggests that this cytogenetically visible variant is not uncommon and may be misinterpreted as a pathogenic imbalance. This frequency could be an underestimate as this EV is usually discernible only in high quality chromosome preparations of at least 550 band level resolution and may have gone undetected in lower resolution chromosomes or where band 8q21.2 is unclear. In addition, Whitby et al 34 found CNVs of RP11-96G1 in 142/1275 (1 in 9) clinically affected patients, which suggests that B1% (9/770) of these CNVs may be microscopically visible. The DGV also indicates that the background frequency of CNVs across the 8q21.2 EV region is high with gains and losses found in 10/49 patients and controls 35 and 9/90 Yoruban individuals. 37 Gains were also found in 26/30 HapMap control samples from four populations, including Yorubans, European-Americans, Japanese and Chinese individuals. 38 In addition, inversions between the 8q21.2 SDs have been detected in individuals of Yoruban and non-African descent. 39 Interestingly, a diploid REXO1L2P median copy number of 172, almost identical to the 173 in our controls, was found using sequencing in 159 ethnically diverse subjects from the 1000 Genomes Project, 32 and the Database of Genomic Structural Variation records 272 copies, within the EV range, of a 7-kb segment including the REXO1L1 gene in a Southern Kalahari hunter-gatherer (KB1). 40 RP11-96G1 at 8q21.2 is the third most common benign CNV identified by Whitby et al 34 using BAC array CGH and, like the second most common (RP11-122N11 at 8p23.1), becomes microscopically visible at high copy number, 31 contains tandemly repeated DNA families, 27 predisposes to polymorphic inversions 41 and has been associated with neocentromere formation. 42 The 8q21.2 VNTR is one of the nine autosomal tandem arrays 42 kb that contain a single gene and show CNV. 27 Three of these nine have been associated with one or more traits including (1) higher copy number of the salivary amylase gene (AMY1) at 1q21.1 with high starch diets; 43 (2) increasing copy number of the 8p23.1 beta defensin genes with higher predisposition to psoriasis, 5, 6 higher human immunodeficiency virus (HIV) load 7 and, possibly, resistance to influenza virus infection; 8 and (3) lower copy number of the CCL3L1 gene at 17q21.1 with weak protection against malarial anaemia 44 and susceptibility to chronic hepatitis C virus (HCV) infection. 45 It is therefore interesting that immunological reaction against the human REXO1L1 gene product (GOR) is a marker of HCV infection including occult HCV in which antibody assays against the HCV are negative. 46 This may simply be a reflection of the partial homology between the GOR epitopes and the HCV-encoded core protein sequence, 46 but it is also conceivable that REXO1L1 copy number affects susceptibility to HCV infection, progression or response to treatment. 47 A critical region including REXO1L1 and a number of candidate genes is amplified in a variety of cancers 48 but overexpression of REXO1L1 in cancer has apparently been recorded only once. 49 In conclusion, we have confirmed the existence of the 8q21.2 EV and mapped the variation to a region containing the 8q21.2 VNTR arrays with multiple copies of a 12-kb repeat and the REXO1L1 gene cluster. We propose that expansion of this VNTR explains the microscopic visibility of the 8q21.2 EVs, which need to be distinguished from pathogenic imbalances especially at prenatal diagnosis. Light microscopically visible imbalances with normal array results may be regarded as a general indicator of the possibility of novel EVs in other parts of the genome.
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